Data suggests that female carriers of inactivating variants in CLCN5 may have mild symptoms of Dent disease such as low-molecular-weight proteinuria, and hypercalciuria with few reported cases of NL and kidney insufficiency (Hoopes et al., 1998). This evidence concerns the gene CLCN5 and Hypercalciuria.